Skip to main content

Table 1 Clinical characteristics of ITP patients

From: Identification of ORM1, vWF, SPARC, and PPBP as immune-related proteins involved in immune thrombocytopenia by quantitative LC-MS/MS

Group 1

Sex/Age (year)

F/18

M/27

F/41

M/45

F/65

Bleeding symptoms

EC

NONE

PT, GUH

EC, GH

EP, GH

Platelet counts (× 10 9 /L)

30

18

17

8

29

Group 2

Sex/Age (year)

F/18

M/33

F/48

F/43

M/60

Bleeding symptoms

PT

GH

GH

EP, GH

EC, GH

Platelet counts (× 10 9 /L)

11

11

12

4

4

Group3

Sex/Age (year)

F/19

F/38

F/43

M/55

M/70

Bleeding symptoms

PT, EC

PT, GUH

EP, GH

GH

NONE

Platelet counts (× 10 9 /L)

9

7

12

3

14

Group 4

Sex/Age (year)

M/25

M/39

F/43

F/48

F/69

Bleeding symptoms

GH, EP

GH

PT, GH

PT, GH

PT, GUH

Platelet counts (× 10 9 /L)

12

14

1

3

8

Median (min–max)

Age (year)

42 (18–70)

Platelet counts (× 10 9 /L)

11 (1–30)

  1. PT = Petechiae, EC = ecchymoses, EP = epistaxis, GUH = genitourinary hemorrhage, GH = gingival hemorrhage